VijiNair United StatesUniversity of Michigan

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 SK1001 HeatherAscani Chairperson ascanihk@med.umich.eduUnited StatesUniversity of Michigan KatherineTuttle Chairperson Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology MatthiasKretzler Chairperson kretzler@umich.eduUnited StatesUniversity of Michigan Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker vijin@med.umich.eduUnited StatesUniversity of Michigan Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker kretzler@umich.eduUnited StatesUniversity of Michigan The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University Panel Discussion Hall C1
10:30 a.m. 11 a.m.	Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy SPOT-O3 Jonathan Barratt Spotlight Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson agnes.fogo@vanderbilt.eduUnited States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A
3 p.m. 4 p.m.	New Tools to Study Kidney Disease SK02 RafaelMaldonado Chairperson ramaldonado@gmail.comArgentina ReikoInagi Chairperson inagi-r@m.u-tokyo.ac.jpJapanThe University of Tokyo Graduate School of Medicine Understanding Glomerular Damage: From Spatial Transcriptomics to Chip Technology LauraPerin Speaker LPerin@chla.usc.eduUnited States Spatial Metabolomics of Kidney Disease TonRabelink Speaker a.j.rabelink@lumc.nlNetherlandsLUMC Constructing an Epigenetic Network for Diabetic Nephropathy Sam El-Osta Speaker sam.el-osta@baker.edu.auAustraliaBaker Heart and Diabetes Institute Q and A Hall E

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Genetics and Genomics of Rare Kidney Disease: ISN-Indian SN Joint Session SK03 PaulaCoccia Chairperson paula.coccia@hospitalitaliano.org.arArgentinaHospital Italianod de Buenos Aires Shyam BihariBansal Chairperson drshyambansal@gmail.comIndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Genomics of Rare Genetic Diseases: Experiences From India VinodScaria Speaker vinods@igib.inIndiaVishwanath Cancer Care Foundation & Indian Institute of Technology Kanpur On the Way to Translate GWAS into Kidney Disease Mechanisms KrzysztofKiryluk Speaker kk473@columbia.eduUnited StatesColumbia University X-linked Kidney Disorders in Women MichelleRheault Speaker rheau002@umn.eduUnited StatesUniversity of Minnesota Prenatal/Preimplantation Genetic Diagnosis and Genetic Counseling for Genetic Kidney Disorders NineKnoers Speaker v.v.a.m.knoers@umcg.nlNetherlandsDepartment of Genetics, University Medical Centre Groningen, Groningen, The Netherlands Q and A Hall E
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10 a.m.	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment LF1002 DebasishBanerjee Chairperson dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Setting the Scene MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustraliaUniversity of New South Wales, Sydney, Australia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London Q and A Hall C4

Time

Session

9 a.m.

10 a.m.

Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment

LF1002

DebasishBanerjee Chairperson dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr

MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia

Setting the Scene

MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
DM and CKD: Which Treatment Should I Use for Different Populations?

KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology
How to Design Studies on Answering Unanswered Questions

VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustraliaUniversity of New South Wales, Sydney, Australia
The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes

DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London
Q and A

Hall C4

Pre-Congress - Saturday April 13, 2024

Time	Session

4:30 p.m. 6 p.m.	WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina) OCPL1 ISN President's Address MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Tribute to Stewart Cameron Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology JorgeRico Speaker jorgericof@yahoo.comColombia MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina Welcome by Minister of Health for Buenos Aries Dr Fern Welcome by SPWG Chair Alessia Fornoni AlessiaFornoni Speaker afornoni@med.miami.eduUnited StatesUniversity of Miami The Origin of the Universe DanielDe Florian Speaker deflo@unsam.edu.arArgentinaUniversidad Nacional de San Martin Acceptance Speech: Hamburger Award AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Hall A

Time

Session

4:30 p.m.

6 p.m.

WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina)

OCPL1

ISN President's Address

MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan
Tribute to Stewart Cameron
Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen
Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair

GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology

JorgeRico Speaker jorgericof@yahoo.comColombia

MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina
Welcome by Minister of Health for Buenos Aries Dr Fern
Welcome by SPWG Chair Alessia Fornoni

AlessiaFornoni Speaker afornoni@med.miami.eduUnited StatesUniversity of Miami
The Origin of the Universe

DanielDe Florian Speaker deflo@unsam.edu.arArgentinaUniversidad Nacional de San Martin
Acceptance Speech: Hamburger Award

AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care

Hall A